Xolair anti-IgE regulatory update

The FDA said its Pulmonary-Allergy Drugs Advisory Committee (PADAC) is next tentatively scheduled to meet on May 11 in a joint session with the Nonprescription Drugs Advisory Committee. PADAC also has...